Travere Therapeutics (TVTX) Earnings Date, Estimates & Call Transcripts $21.98 -1.60 (-6.79%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$22.26 +0.27 (+1.25%) As of 02/21/2025 06:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Travere Therapeutics Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 5After Market ClosesEstimatedActual EPS (Feb. 20) -$0.73 Missed By -$0.15 Consensus EPS (Feb. 20) -$0.58 Travere Therapeutics posted Q4 2024 earnings on February 20, 2025, reporting an EPS of -$0.73, which missed the consensus estimate of -$0.58 by $0.15. Quarterly revenue was reported to be $74.79 million, above the consensus estimate of $72.38 million. With a trailing EPS of -$4.55, Travere Therapeutics' earnings are expected to grow next year, from ($3.90) to ($1.40) per share. Conference CallSEC 10-Q/10-K FilingTVTX Upcoming EarningsTravere Therapeutics' next earnings date is estimated for Monday, May 5, 2025, based off prior year's reporting schedules. Get Travere Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Travere Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTVTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TVTX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Travere Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.59-$0.42-$0.48Q2 20253-$0.43-$0.18-$0.28Q3 20253-$0.34-$0.05-$0.20Q4 20253-$0.04$0.32$0.14FY 202512($1.40)($0.33)($0.82) Travere Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/5/2025(Estimated)-------2/20/2025Q4 2024-$0.58-$0.73 -$0.15-$0.73$72.38M$74.79M10/31/2024Q3 2024-$0.71-$0.70+$0.01-$0.70$60.87M$62.90M8/1/2024Q2 2024-$0.87-$0.90 -$0.03-$0.89$49.50M$54.12M5/6/2024Q1 2024-$0.98-$1.76 -$0.78-$1.76$43.46M$41.40M2/15/2024Q4 2023-$1.27-$1.16+$0.11-$1.14$41.25M$45.06M11/7/2023Q3 2023-$1.09-$1.17 -$0.08-$4.31$132.01M$37.10M8/3/2023Q2 2023-$1.16-$1.13+$0.03-$1.13$53.93M$59.70M5/4/2023Q1 2023-$1.18-$1.27 -$0.09-$1.27$50.93M$56.99M2/23/2023Q4 2022-$1.04-$1.03+$0.01-$1.03$54.80M$55.87M Travere Therapeutics Earnings - Frequently Asked Questions When is Travere Therapeutics's earnings date? Travere Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 5th, 2025 based off last year's report dates. Learn more on TVTX's earnings history. Did Travere Therapeutics beat their earnings estimates last quarter? In the previous quarter, Travere Therapeutics (NASDAQ:TVTX) missed the analysts' consensus estimate of ($0.58) by $0.15 with a reported earnings per share (EPS) of ($0.73). Learn more on analysts' earnings estimate vs. TVTX's actual earnings. How can I listen to Travere Therapeutics's earnings conference call? The conference call for Travere Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I view Travere Therapeutics's earnings report? Travere Therapeutics's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Travere Therapeutics generate each year? Travere Therapeutics (NASDAQ:TVTX) has a recorded annual revenue of $203.45 million. How much profit does Travere Therapeutics generate each year? Travere Therapeutics (NASDAQ:TVTX) has a recorded net income of -$111.40 million. TVTX has generated -$4.55 earnings per share over the last four quarters. What is Travere Therapeutics's EPS forecast for next year? Travere Therapeutics's earnings are expected to grow from ($3.90) per share to ($1.40) per share in the next year. More Earnings Resources from MarketBeat Related Companies Revolution Medicines Earnings Legend Biotech Earnings BridgeBio Pharma Earnings Axsome Therapeutics Earnings Blueprint Medicines Earnings Elanco Animal Health Earnings Lantheus Earnings Nuvalent Earnings Cytokinetics Earnings Verona Pharma Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Hims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before EarningsAirbnb's Earnings: Sky High Results, Grounded Guidance?Is Coinbase Stock a Buy After Earnings?CVS Health: Earnings Beat Ignites Stock RallyQualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?Cirrus Logic Upgraded After Q3 Earnings Beat—More Gains Ahead? This page (NASDAQ:TVTX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Travere Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Travere Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TVTX Stock Alerts